Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

EMD-1204831 shows antitumor activity in preclinical studies

April 15, 2011

Clinical phase I and II data presented on TMC-435 for hepatitis C

April 15, 2011

Acetone level in exhaled breath as a new biomarker of heart failure

April 15, 2011

Merck & Co. describes new inhibitors of MAP/microtubule affinity-regulating kinase 3

April 15, 2011

TAK-075 is a new, stable, orally active bone anabolic agent for osteoporosis

April 15, 2011

Levels of pentraxin-related protein PTX3 may predict unresponsiveness to IVIG in Kawasaki's disease

April 14, 2011

Pfizer's new HSP 90 inhibitor PF-4942847 shows promise in triple-negative breast cancer in vivo

April 14, 2011

First-in-human data reported on GDC-0973 alone and in combination with GDC-0941

April 14, 2011

Abbott presents new ROCK-2 inhibitor with high specificity and selectivity

April 14, 2011

Janssen Pharma's new analgesics JNJ-40413269 and JNJ-40534832 show promise in vivo

April 13, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 5, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...